TLDR:
Cosmos Health secures a $300M facility to build a strategic Ethereum-based treasury reserve.
At least 72.5% of each capital tranche must go directly into Ethereum purchases and staking.
BitGo Trust will manage custody and staking, ensuring ETH contributes to long-term yield.
CEO Greg Siokas says digital assets are now central to Cosmos Health’s transformation strategy.
Cosmos Health is going crypto. The healthcare firm has locked in a financing facility worth up to $300 million to load up on Ethereum. It’s not a gimmick.
This move kicks off a structured digital asset treasury strategy that will be anchored around ETH. The goal? Use Ethereum to fuel long-term shareholder value while stepping into the crypto economy in a calculated, institutional way.
Here’s how they plan to do it.
Ethereum Treasury Reserve Becomes the Centerpiece
On August 6, Cosmos Health said it signed a securities purchase agreement with a U.S. institutional investor. The agreement allows the company to issue senior secured convertible notes totaling up to $300 million. At least 72.5% of each funding tranche must go toward Ethereum purchases.
The rest will support working capital and other business growth efforts. According to the company, this is more than a treasury diversification move. It’s a strategic pivot to a digital-native reserve structure.
The ETH Cosmos buys won’t sit idle. BitGo Trust Company will manage secure custody and staking, ensuring the assets generate yield. By putting the ETH to work, Cosmos is aiming to increase both treasury value and ETH-per-share over time.
This aligns with their wider digital transformation efforts, according to the statement. The company hinted at using blockchain for real-world traceability, wellness programs, and broader e-commerce innovation.
Leadership Doubles Down on the Long Game
Cosmos Health CEO Greg Siokas made it clear this wasn’t a quick crypto play. He said the company views digital assets as a core pillar in its forward strategy. This includes accelerating product development, strengthening R&D, and eventually moving into U.S. manufacturing.
Siokas called the financing a “strategic milestone” that adds ETH exposure while securing growth capital. That exposure, he said, gives investors a path into one of the most widely adopted digital assets, all within a listed healthcare stock.
To make this deal happen, Cosmos Health tapped Curvature Securities, LLC as the sole placement agent. The firm is helping manage how capital flows into the project through structured tranches.
Each tranche must meet specific requirements before execution, but once cleared, Cosmos can gradually build its Ethereum holdings at scale. Investors are watching closely to see if this playbook becomes a blueprint for others in traditional sectors looking to enter crypto with control and oversight.
Cosmos Health has taken a bold step. Now, it’s a question of how quickly the ETH strategy starts showing real results.
